Israel’s Edity Therapeutics reprograms immune cells to recognize tumors that hide from the body’s regular immune system. Edity’s ED 007 cell therapy inflames these tumors, triggering the body’s own immune system to kill the cancer without risk of side effects or rejection.

https://www.timesofisrael.com/spotlight/meet-007-the-cell-with-a-license-to-kill-cancer-created-by-an-israeli-startup/

https://edity-tx.com/

https://www.youtube.com/watch?v=LBEl1TwExmo